2026 NPPES data Medical Oncology Physician NPI 1013925650 MD
Verify on CMS →

MICHELLE BOYAR, MD

Medical Oncology Physician in BRONXVILLE, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
779
Medicare Part D claims · 89 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$18.09
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MICHELLE BOYAR, MD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 779 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
779
Part D claims, 2023
80%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHELLE BOYAR, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MICHELLE BOYAR, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHELLE BOYAR, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/03/2006

NPI 1013925650

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

779 13% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Medical Oncology Physician compares to other specialties among New York providers

New York providers

Medical Oncology Physician share within New York

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within New York

Medicare quality performance — MIPS

MICHELLE BOYAR, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHELLE BOYAR, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 55 PALMER AVE, BRONXVILLE, NY, 10708, with a listed phone of (914) 787-3100. NPI 1013925650 was issued on 08/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOYAR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 779 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 15.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8066), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

55 PALMER AVE
BRONXVILLE, NY 10708

Provider Details

NPI 1013925650
Specialty Medical Oncology Physician
Credentials MD
Gender Female
NPI Issued 08/03/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
86.8066
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MICHELLE BOYAR, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LAWRENCE MEDICAL ASSOCIATES PC
BRONXVILLE, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHELLE BOYAR, MD. Source: openpaymentsdata.cms.gov.

Total received

$18

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MICHELLE BOYAR, MD. To verify MICHELLE BOYAR, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MICHELLE BOYAR, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 779 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

779
Total Claims
$1.1M
Total Drug Cost
89
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,002
Total Day Supply
26,887
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$861K
Generic Drug Cost
$288K
Opioid Claims
117 (15.0% rate)
Antibiotic Claims
15

Patient Demographics

Average Patient Age
76.5 years
Avg HCC Risk Score
2.75
Gender Split
40% female / 60% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MICHELLE BOYAR, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
51
Abiraterone Acetate
46
Ondansetron Hcl
45
Oxycodone Hcl
43
Amlodipine Besylate
32
Omeprazole
28
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
28
Creon
Lipase/Protease/Amylase
27
Furosemide
27
Morphine Sulfate Er
Morphine Sulfate
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MICHELLE BOYAR, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MICHELLE BOYAR, MD's 779 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BOYAR.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHELLE BOYAR, MD's specialty?
MICHELLE BOYAR, MD specializes in Medical Oncology Physician and practices in BRONXVILLE, New York. Credentials: MD.
How much does MICHELLE BOYAR, MD prescribe under Medicare Part D?
In 2023, MICHELLE BOYAR, MD wrote 779 Medicare Part D claims totaling $1.1M in drug costs for 89 beneficiaries.
What is MICHELLE BOYAR, MD's Medicare quality score?
MICHELLE BOYAR, MD has a CMS MIPS Final Score of 100/100 (Quality: 86.8066). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHELLE BOYAR, MD located?
MICHELLE BOYAR, MD is located at 55 PALMER AVE, BRONXVILLE, NY, 10708. Phone: (914) 787-3100.
What is MICHELLE BOYAR, MD's NPI number?
MICHELLE BOYAR, MD's National Provider Identifier (NPI) is 1013925650, issued on 08/03/2006.
Does MICHELLE BOYAR, MD prescribe more brand-name or generic drugs?
MICHELLE BOYAR, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $861K in brand drug costs.
Does MICHELLE BOYAR, MD prescribe opioids?
Yes, MICHELLE BOYAR, MD had 117 opioid claims in 2023 with an opioid prescribing rate of 15.0%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MICHELLE BOYAR, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHELLE BOYAR, MD's most frequently prescribed drugs include Prednisone, Abiraterone Acetate, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHELLE BOYAR, MD accept Medicare?
MICHELLE BOYAR, MD appears in CMS Medicare data with 779 Part D claims and 89 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHELLE BOYAR, MD's credentials?
MICHELLE BOYAR, MD's NPI is 1013925650 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology